UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059233
Receipt number R000067751
Scientific Title High-protein nutrition in ICU patients undergoing advanced early mobilization
Date of disclosure of the study information 2025/09/29
Last modified on 2025/09/29 19:24:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

High-protein nutrition in ICU patients undergoing advanced early mobilization

Acronym

High-protein nutrition in ICU patients undergoing advanced early mobilization

Scientific Title

High-protein nutrition in ICU patients undergoing advanced early mobilization

Scientific Title:Acronym

High-protein nutrition in ICU patients undergoing advanced early mobilization

Region

Japan


Condition

Condition

ICU patients

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Cardiology Pneumology Endocrinology and Metabolism
Hematology and clinical oncology Nephrology Clinical immunology
Infectious disease Surgery in general Gastrointestinal surgery
Hepato-biliary-pancreatic surgery Vascular surgery Chest surgery
Endocrine surgery Breast surgery Obstetrics and Gynecology
Orthopedics Anesthesiology Neurosurgery
Cardiovascular surgery Operative medicine Emergency medicine
Blood transfusion Intensive care medicine Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This trial aims to investigate whether combining high-protein nutrition with early mobilization can promote physical and functional recovery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is the motor score of the Functional Independence Measure (FIM) at hospital discharge

Key secondary outcomes

At ICU discharge: Functional Status Score for the ICU (FSS-ICU) [27], Medical Research Council (MRC) score, and ICU length of stay.
At 14 days after ICU discharge: FIM motor, FIM cognitive (FIM cog), Mini-Mental State Examination (MMSE), body composition parameters, MRC score, and Brief Pain Inventory (BPI).
At hospital discharge: MRC score, FIM cog, body composition parameters, BPI, length of hospital stay, and mortality.
At 60 days after hospital discharge: FIM motor score, MRC score, FIM cog, MMSE score, body composition parameters, and BPI


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

In the control group, nutritional administration is targeted at the lower limit of the protein level (1.2 g/kg/day) indicated in each guideline. The intervention group will be fed at 1.8 g/kg/day of protein.

Interventions/Control_2

In the control group, nutritional administration is targeted at the lower limit of the protein level (1.2 g/kg/day) indicated in each guideline. The intervention group will be fed at 1.8 g/kg/day of protein.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion criteria were (1) general or emergency (ICU) inpatients aged 18 years or older, (2) independent of ADLs prior to admission, and (3) patients expected to remain on a ventilator for at least 48 hours.

Key exclusion criteria

Exclusion criteria are (1) scheduled surgical patients, (2) patients weighing 200 kg or more (due to device weight capacity of up to 200 kg), (3) patients admitted for neuromuscular disease, (4) patients with leg loss or load limitation due to post-hospitalization surgery, (5) patients transferred after 48 hours of ventilation, (6) patients for whom enteral nutrition is impossible; and (7) patients expected to die within 7 days.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Ginga
Middle name
Last name Suzuki

Organization

Toho University Omori Medical Center

Division name

Critical Care Center

Zip code

1438541

Address

6-11-1, Omori-Nishi, Ota-ku, Tokyo, Japan

TEL

0337624151

Email

ginga.suzuki@med.toho-u.ac.jp


Public contact

Name of contact person

1st name Ginga
Middle name
Last name Suzuki

Organization

Toho University Omori Medical Center

Division name

Critical Care Center

Zip code

1438541

Address

6-11-1, Omori-Nishi, Ota-ku, Tokyo, Japan

TEL

0337624151

Homepage URL


Email

ginga.suzuki@med.toho-u.ac.jp


Sponsor or person

Institute

Other

Institute

Department

Personal name

Ginga Suzuki


Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethics Committee of Toho University School of Medicine

Address

6-11-1, Omori-Nishi, Ota-ku, Tokyo, Japan

Tel

0337624151

Email

med.rinri@ext.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 09 Month 10 Day

Date of IRB

2025 Year 09 Month 05 Day

Anticipated trial start date

2025 Year 09 Month 30 Day

Last follow-up date

2027 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 09 Month 29 Day

Last modified on

2025 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067751